Medicare Enrolled
Dr. Reuben Azad, MD
Cardiovascular Disease · Philadelphia, PA
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Azad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Azad?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Azad
Dr. Reuben Azad is a cardiovascular disease specialist in Philadelphia, PA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Azad performed 3,059 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Azad received a total of $8,366 from 31 pharmaceutical and/or device companies across 326 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Azad is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years of NPI registration
▲ Top 28% volume in PA
$8,366 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,059
Medicare services
Top 28% in PA for cardiovascular disease
Not available
Unique patients (not deduplicated)
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
494 | $11 | $70 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
460 | $43 | $140 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
418 | $97 | $190 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
407 | $117 | $531 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
405 | $93 | $275 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
169 | $51 | $450 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
166 | $365 | $1,150 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
166 | $47 | $795 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
109 | $107 | $245 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
85 | $115 | $350 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
65 | $8 | $25 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
32 | $142 | $360 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
15 | $2 | $15 |
| 2-day continuous ECG monitoring A continuous electrocardiogram recording that captures heart activity over a 48-hour period. This test helps detect irregular heart rhythms or other cardiac issues that may not appear during a standard, short-term ECG. |
14 | $13 | $150 |
| 2-day continuous ECG with professional review A two-day continuous electrocardiogram recording that includes a review by a healthcare professional. |
14 | $12 | $150 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
14 | $86 | $305 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
14 | $14 | $60 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
12 | $65 | $130 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
13.8% high complexity
34.5% medium
51.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,366
Total received (2018-2024)
Avg $1,195/year across 7 years
Top 24% in PA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
326
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$470
2023
$819
2022
$1,918
2021
$1,817
2020
$361
2019
$2,662
2018
$320
Payments by company (2024)
Lexicon Pharmaceuticals, Inc.
$119
Boehringer Ingelheim Pharmaceuticals, Inc.
$52
Edwards Lifesciences Corporation
$43
Merck Sharp & Dohme LLC
$39
Novartis Pharmaceuticals Corporation
$31
SANOFI-AVENTIS U.S. LLC
$29
AstraZeneca Pharmaceuticals LP
$29
Biosense Webster, Inc.
$26
Biogen, Inc.
$26
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$24
AGEPHA Pharma FZ LLC
$17
SCPHARMACEUTICALS INC.
$17
Amgen Inc.
$17
Top 3 companies account for 45.7% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$5,111
Novartis Pharmaceuticals Corporation
$493
Impulse Dynamics (USA) Inc.
$386
Astellas Pharma US Inc
$373
Janssen Pharmaceuticals, Inc
$349
SANOFI-AVENTIS U.S. LLC
$201
Lexicon Pharmaceuticals, Inc.
$171
BOSTON SCIENTIFIC CORPORATION
$168
PFIZER INC.
$125
E.R. Squibb & Sons, L.L.C.
$117
Boehringer Ingelheim Pharmaceuticals, Inc.
$114
Amgen Inc.
$114
Merck Sharp & Dohme LLC
$88
AstraZeneca Pharmaceuticals LP
$86
Biosense Webster, Inc.
$81
Edwards Lifesciences Corporation
$61
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$47
ABIOMED
$30
Bardy Diagnostics, Inc.
$30
Siemens Medical Solutions USA, Inc.
$28
Biogen, Inc.
$26
Azurity Pharmaceuticals, Inc.
$21
Cook Medical LLC
$20
Alnylam Pharmaceuticals Inc.
$18
AGEPHA Pharma FZ LLC
$17
SCPHARMACEUTICALS INC.
$17
Lantheus Medical Imaging, Inc.
$17
Merck Sharp & Dohme Corporation
$15
Bayer HealthCare Pharmaceuticals Inc.
$15
Amarin Pharma Inc.
$14
Kiniksa Pharmaceuticals, Ltd.
$13
Top 3 companies account for 71.6% of all-time payments
Associated products mentioned in payments ›
AMVUTTRA · Allure Quadra RF CRT Pacemaker · Arcalyst · Assurity Pacemaker · CAMZYOS · CARTO 3 · CardioMEMS HF System · Carnation Ambulatory Monitor · Confirm Rx · CorPath Imaging System · DEFINITY · DRAGONFLY OPSTAR · Dragonfly OCT · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · Edarbi · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ensite Cardiac Mapping System · FARXIGA · FUROSCIX · FlexAbility Ablation Catheter · GENERAL THERAPIES · HeartMate 3 Left Ventricular Assist Device · Impella · Inpefa · JARDIANCE · JETSTREAM · Kerendia · LEQVIO · LODOCO · Legacy · LifeVest · MULTAQ · Merlin Connectivity and Remote · NC TREK NEO · OPTIMIZER · OPTIS · Optimizer · Optimizer Smart System · Optis Coronary Imaging System · PRESSUREWIRE · PressureWire FFR · Quadra Allure MP RF CRT Pacemkr · Repatha · SKYCLARYS · VERQUVO · VYNDAQEL · Vascepa · XARELTO · XIENCE SIERRA · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System · Zilver PTX
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
726
County median income
$60,698
Nearest hospital to ZIP centroid (approximate)
JEFFERSON HEALTH- NORTHEAST
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Azad is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 28% in PA).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Azad experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Azad performed 494 electrocardiogram (ekg), 12-lead services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Azad receive payments from pharmaceutical companies?
Yes. Dr. Azad received a total of $8,366 from 31 companies across 326 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Azad's costs compare to other cardiologists in Philadelphia?
Dr. Azad's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Azad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Philadelphia
Browse cardiologists in Philadelphia ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in PA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in PA
Which PA cardiologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Impulse Dynamics (USA) Inc. Payments to Doctors
See all physicians who received payments from Impulse Dynamics (USA) Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology